Search hospitals > Missouri > Kansas City
North Kansas City Hospital
Claim this profileKansas City, Missouri 64116
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Leukemia
Conducts research for Lung Cancer
161 reported clinical trials
2 medical researchers
Summary
North Kansas City Hospital is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Leukemia, Lung Cancer and other specialties. North Kansas City Hospital is involved with conducting 161 clinical trials across 274 conditions. There are 2 research doctors associated with this hospital, such as Zafir Hawa, MD and Larry Hollenbeck.Area of expertise
1Cancer
Global LeaderStage III
Stage IV
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Zafir Hawa, MDNorth Kansas City Hospital2 years of reported clinical research
Studies Cardiovascular Disease
Studies Atherosclerosis
1 reported clinical trial
1 drug studied
Larry HollenbeckNorth Kansas City Hospital4 years of reported clinical research
Studies Alzheimer's Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at North Kansas City Hospital
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Laryngeal Squamous Cell Carcinoma
Oral Squamous Cell Carcinoma
Cardiovascular Disease
Bleeding
Emergency Surgery
Invasive Procedure
Colorectal Cancer
Adenoma
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at North Kansas City Hospital?
North Kansas City Hospital is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Leukemia, Lung Cancer and other specialties. North Kansas City Hospital is involved with conducting 161 clinical trials across 274 conditions. There are 2 research doctors associated with this hospital, such as Zafir Hawa, MD and Larry Hollenbeck.